The virtual tour allows decision makers in the IVD industry located in any part of the world to easily and quickly pre-audit the first-class clean room facility from their own computer without the need for expensive travel. Each of the classified clean rooms in the facility can be viewed in detail using interactive viewing features.
“The virtual tour provides decision makers evaluating Eurogentec as a potential supplier of custom-synthesized IVD oligonucleotides, an easy and innovative tool to pre-audit our GMP/QSR manufacturing facility and get a great impression of the extraordinary measures we have taken to minimize the risk of contamination,” says Dr. Peter Haima, Eurogentec’s Director for Diagnostic Services. “In June this year, we also plan to obtain ISO13485 certification of our GMP/QSR compliant clean room oligo production facility in North America. With this certification of its US site, Eurogentec’s strategic plan for having fully harmonized ISO13485-certified facilities in Europe, North America and Asia will be completed. Together, our harmonized global network of manufacturing facilities ensures our diagnostic clients an uninterrupted supply of cGMP-grade oligos.”